Invited reply to Amikacin ototoxicity in children with cancer: The problem is the administration schedule

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|61|2|191-191

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.61, Iss.2, 2014-02, pp. : 191-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Administration schedule and ototoxicity of amikacin in children with cancer

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 192-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of ototoxicity of intratympanic administration of Auralgan in a chinchilla animal model

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 6, 2015-06 ,pp. : 1444-1448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Difference in Neutropenia due to Administration Schedule of TAS-102

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-03 ,pp. : 226-229

Karger

Access to resources Recommend Favorite

The problem of treatment abandonment in children from developing countries with cancer

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 941-946

John Wiley & Sons Inc

Access to resources Recommend Favorite

Invited reply on PBC‐13‐0662.R2: Biomarkers and wilms tumor

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 185-186

John Wiley & Sons Inc

Access to resources Recommend Favorite